Medical Products
Who acquires Medical Products companies
Boston Scientific has bought the most Medical Products companies in our records: 13 acquisitions, the latest in 2025. In all, 298 named buyers completed 434 recorded Medical Products transactions, 2014 to 2026, and 65 of them bought more than once. Every buyer below has completed at least one acquisition in this sector.
Top 10 acquirers of Medical Products companies
Ranked by number of acquisitions recorded in this sector, with the year of each buyer's latest one. A buyer that has done this more than once has a thesis, and a thesis is what makes an approach worth making.
| Acquirer | Deals here | Last deal |
|---|---|---|
| Boston Scientific | 13 | 2025 |
| Merit Medical | 9 | 2025 |
| Medtronic | 9 | 2017 |
| Stryker | 8 | 2025 |
| Cantel Medical Corp. | 7 | 2019 |
| Hologic | 5 | 2024 |
| Cooper Companies | 5 | 2024 |
| Smith & Nephew | 5 | 2023 |
| Conmed | 4 | 2022 |
| Edwards | 4 | 2019 |
Counted from 434 recorded transactions, 2014 to 2026. Name variants of the same buyer (Inc, Corporation, Ltd) are counted together.
Get the 25 most likely buyers for a business your size, $149
Ranked for your deal size and, if you choose, your state: deals in Medical Products, deals at your size, how recently each buyer bought, and its activity in neighbouring sectors. The score is published and the first three are free to preview.
All 434 Medical Products deals on file, with multiples where disclosed and the source on every row, as Excel and CSV: Medical Products pack, $95. Every sector: full archive of 11,318 deals, $495.
Would these buyers pay for yours?
Put a number on it first: run the free estimate, then the $199 written report sets your range against the Medical Products band and the comparable disclosed deals, in a document you can share. If the business is profitable, has $1M or more of revenue and you may sell within two years, talk to our advisory team about which of these buyers would engage, and at what price. The first conversation is free.
How Medical Products deals priced over time
Medians by period, each with the number of deals behind it. A median from fewer than 5 disclosed figures is withheld and the count shown instead.
The table scrolls sideways for deal size and count.
| Period | EV/EBITDA | EV/Revenue | Median deal size | Deals |
|---|---|---|---|---|
| 2014 to 2016 | 10.6xn=10 | 2.3xn=33 | $69mn=120 | 120 |
| 2017 to 2019 | -n=3 | 2.5xn=23 | $103mn=114 | 114 |
| 2020 to 2022 | -n=3 | 4.0xn=16 | $118mn=101 | 101 |
| 2023 to 2026 | -n=1 | 3.1xn=16 | $103mn=79 | 99 |
n is the number of deals in the period that disclosed that figure. Dashes are medians withheld for want of evidence, not zeros.
How big Medical Products acquisitions are
414 of 434 transactions disclosed a value; 36% of those were under $50m.
- Under $10m
- 47 (11%)
- $10m to $50m
- 101 (24%)
- $50m to $250m
- 148 (36%)
- $250m to $1bn
- 113 (27%)
- $1bn and over
- 5 (1%)
Who the buyers are
Buyer head office
- United States250 (65%)
- United Kingdom34 (9%)
- Canada18 (5%)
- Ireland13 (3%)
- Sweden12 (3%)
From 385 deals where the buyer's head office is recorded.
Recorded transactions
The table scrolls sideways for value and multiples.
| Target | Acquirer | Date | Value | EV/EBITDA | EV/Revenue |
|---|---|---|---|---|---|
| LogicMark | Langham Project LLC | 2026-10-13 | n/d | n/d | n/d |
| SimpliDerm Business | Cellution Biologics Inc. | 2026-08-17 | $8m | n/d | n/d |
| Teleflex OEM Business | Montagu and Kohlberg | 2026-08-03 | $1.5bn | n/d | n/d |
| Avanos Medical | American Industrial Partners | 2026-07-27 | $1.3bn | n/d | 1.8xc |
| Riverpoint Medical | Novanta Inc. | 2026-07-23 | $1.2bn | n/d | n/d |
| Vision Renu Corporation | SUIC Worldwide Holdings Ltd. | 2026-07-10 | n/d | n/d | n/d |
| B Medical Systems S.à r.l. | Thelema S.à r.l. | 2026-07-01 | $63m | n/d | n/d |
| CareDx Lab Products business | Eurobio Scientific S.A. | 2026-06-30 | $172m | n/d | n/d |
| Lucerno Dynamics Lara System and Ellexa Explorer business | Radnostix | 2026-06-25 | $900k | n/d | n/d |
| Masimo Corporation | Danaher Corporation | 2026-06-10 | n/d | n/d | n/d |
| Owen Mumford Holdings Limited | Embecta Corp. | 2026-05-15 | n/d | n/d | n/d |
| Acellent Technologies (Hong Kong) Co. Limited | Advanced Biomed Inc. | 2026-04-30 | $1m | n/d | n/d |
| Celularity regenerative biomaterials business | NexGel | 2026-04-17 | $13m | n/d | n/d |
| Hologic | Blackstone Inc. and TPG Global | 2026-04-07 | n/d | n/d | n/d |
| Exact Sciences Corporation | Abbott Laboratories | 2026-03-23 | n/d | n/d | n/d |
| Woori IO Co. | OSR Holdings | 2026-01-26 | n/d | n/d | n/d |
| Semler Scientific | Strive | 2026-01-16 | n/d | n/d | n/d |
| SLED Distribution | Acme United Corporation | 2026-01-15 | $18m | n/d | 0.9x |
| Owens & Minor Products & Healthcare Services business | Platinum Equity | 2025-12-31 | $375m | n/d | n/d |
| SaltMED | Micro Imaging Technology | 2025-12-24 | n/d | n/d | n/d |
| Xtant Coflex/CoFix product line and Paradigm Spine GmbH | Companion Spine | 2025-12-01 | $19m | n/d | n/d |
| Liora Technologies Europe Ltd. | LIXTE Biotechnology Holdings | 2025-11-25 | n/d | n/d | n/d |
| IRRAS Holdings | ClearPoint Neuro | 2025-11-20 | n/d | n/d | n/d |
| Surmodics | BCE Parent | 2025-11-19 | n/d | n/d | n/d |
| ZimVie Inc. | ARCHIMED | 2025-10-20 | n/d | n/d | n/d |
| Monogram Technologies Inc. | Zimmer Biomet Holdings | 2025-10-07 | n/d | n/d | n/d |
| Elutia CIED Business | Boston Scientific Corporation | 2025-10-01 | $88m | n/d | n/d |
| Accelerate Diagnostics | Indaba Capital Management | 2025-08-08 | n/d | n/d | n/d |
| SiVantage SImmetry business | Tenon Medical | 2025-08-01 | n/d | n/d | n/d |
| UNIPEC | UFP TECHNOLOGIES INC | 2025-07-17 | $8m | n/d | 1.5x |
| World Reach Holdings | Papyrus Distribution LLC | 2025-06-13 | n/d | n/d | n/d |
| Trelegy Ellipta | GSK | 2025-06-02 | $225m | n/d | n/d |
| Biolife | Merit Medical | 2025-05-20 | $120m | n/d | n/d |
| NeuroMetrix | electroCore | 2025-05-02 | n/d | n/d | n/d |
| Paragon 28 | Zimmer Biomet | 2025-04-21 | n/d | n/d | n/d |
| iCAD | RadNet | 2025-04-15 | $103m | n/d | 5.4x |
| Natech | Quaker Chemical | 2025-04-01 | $6m | n/d | n/d |
| LENSAR | Alcon | 2025-03-24 | $430m | n/d | 8.1x |
| OptiNose | Paratek Pharmaceuticals | 2025-03-19 | $330m | n/d | n/d |
| Parcus Medical | Medacta Group SA | 2025-03-07 | $5m | n/d | n/d |
| Biotronik's Vascular Intervention Business | Teleflex | 2025-02-27 | $856m | n/d | n/d |
| Inari Medical | Stryker Corporation | 2025-02-19 | $4.9bn | n/d | 8.6xc |
| ENvue Medical Holdings | NanoVibronix | 2025-02-14 | n/d | n/d | n/d |
| Nevro | Globus Medical | 2025-02-06 | $250m | n/d | n/d |
| Vantive Health LLC | CP Spruce Holdings | 2025-01-31 | $3.8bn | n/d | n/d |
| Avenova eyecare business | PRN Physician Recommended Nutriceuticals | 2025-01-17 | $12m | n/d | n/d |
| Veru FC2 female condom business | Clear Future | 2024-12-30 | $18m | n/d | n/d |
| Alzet Osmotic Pumps | Lafayette Instrument | 2024-11-25 | $18m | n/d | n/d |
| Cook Medical - Lead Management Business | Merit Medical | 2024-11-01 | $210m | n/d | n/d |
| Arthrosurface | Phoenix Brio | 2024-10-31 | $10m | n/d | n/d |
| Gynesonics | Hologic | 2024-10-14 | $350m | n/d | n/d |
| Bioventus - Advanced Rehabilitation Business | Accelmed (PE) | 2024-10-01 | $45m | n/d | n/d |
| Avenova Eyecare | Acumen Health Holdings | 2024-09-20 | $12m | n/d | n/d |
| Therakos | CVC Capital Partners (PE) | 2024-08-05 | $925m | n/d | n/d |
| Ecolab - Global Surgical Solutions Business | Medline | 2024-08-01 | $950m | n/d | n/d |
| obp Surgical | Cooper Companies | 2024-08-01 | $100m | n/d | n/d |
| Hamilton Thorne | Astorg Partners (PE) | 2024-07-22 | $388m | w/h | 5.8x |
| Intelligent Ultrasound AI Business | GE Healthcare | 2024-07-18 | $51m | n/d | n/d |
| SciAps | Spectris | 2024-07-04 | $260m | n/d | n/d |
| EndoGastric Solutions | Merit Medical | 2024-07-01 | $105m | n/d | n/d |
| Agile | Insud Pharma | 2024-06-26 | $45m | n/d | 2.1x |
| SurModics | GTCR (PE) | 2024-05-29 | $627m | 23.2x | 4.7x |
| Atrion | Nordson | 2024-05-28 | $815m | n/d | 4.8x |
| HuFriedyGroup | Peak Rock Capital (PE) | 2024-04-11 | $788m | n/d | n/d |
| Medical Device Components | Montagu (PE) | 2024-03-20 | $847m | n/d | n/d |
| DERMAdoctor | Undisclosed | 2024-03-14 | $1m | n/d | n/d |
| AngioDynamics - PICC & Midline Product Portfolios | Spectrum Vascular | 2024-02-15 | $45m | n/d | n/d |
| WaveForm Technologies - CGM Assets | Trinity Biotech | 2024-01-31 | $13m | n/d | n/d |
| Pulse Technologies | Integer | 2024-01-10 | $140m | n/d | n/d |
| Boston Orthotics & Prosthetics | OrthoPediatrics | 2024-01-08 | $22m | n/d | 0.9x |
| Highridge Medical | H.I.G. Private Equity (PE) | 2023-12-18 | $375m | n/d | n/d |
| Acclarent | Integra LifeSciences | 2023-12-13 | $275m | n/d | n/d |
| Laminar | Johnson & Johnson MedTech | 2023-11-30 | $400m | n/d | n/d |
| Vyrsa | Nevro | 2023-11-30 | $75m | n/d | n/d |
| CartiHeal | Smith & Nephew | 2023-11-24 | $330m | n/d | n/d |
| Hospitex | Ikonisys | 2023-11-23 | $5m | n/d | 2.5x |
| LimFlow | Inari Medical | 2023-11-01 | $250m | n/d | n/d |
| Healthmark | Getinge | 2023-10-11 | $320m | n/d | n/d |
| OpSens | Haemonetics | 2023-10-10 | $253m | n/d | n/d |
| Limacorporate | Enovis | 2023-09-25 | $902m | n/d | n/d |
| Relievant Medsystems | Boston Scientific | 2023-09-18 | $850m | n/d | n/d |
| Optilume BPH | Laborie Medical Technologies | 2023-09-06 | $600m | n/d | n/d |
| Epigenomics | New Day Diagnostics | 2023-07-24 | $12m | n/d | n/d |
| Physio-Assist | Inogen | 2023-07-13 | $32m | n/d | n/d |
| Becton | Steris | 2023-06-20 | $540m | n/d | n/d |
| AngioDynamics' Dialysis Catheter Portfolio & BioSentry Biopsy Tract Sealant System | Merit Medical | 2023-06-08 | $100m | n/d | n/d |
| Bluegrass Vascular Technologies - Surfacer® Inside-Out® Access Catheter System | Merit Medical | 2023-06-08 | $33m | n/d | n/d |
| HPNE | Getinge | 2023-05-31 | $290m | n/d | n/d |
| Lucira | Pfizer | 2023-04-28 | $36m | n/d | n/d |
| Remi Robotic Navigation System | Alphatec | 2023-04-19 | $55m | n/d | n/d |
| Home Medical Products | VieMed | 2023-04-18 | $32m | n/d | 1.1x |
| Surgalign's Coflex Product Line | Xtant Medical | 2023-03-01 | $17m | n/d | n/d |
| Bigfoot Biomedical - Insulin Pump Patents | Insulet | 2023-02-13 | $25m | n/d | n/d |
| CSI | Abbott | 2023-02-08 | $890m | n/d | 3.8x |
| PreCon Health | Thorne HealthTech | 2023-02-03 | $5m | n/d | n/d |
| Chembio Diagnostics | Biosynex | 2023-01-31 | $17m | n/d | 0.5x |
| Devi Holdings - Maryland assets | AWH | 2023-01-25 | $19m | n/d | n/d |
| Neovasc | ShockWave Medical | 2023-01-17 | $100m | n/d | 32.2x |
| Verogen | Qiagen N.V | 2023-01-09 | $150m | n/d | n/d |
| Vivacy | Bridgepoint (PE) | 2022-11-30 | $975m | n/d | n/d |
| Ohio Medical | Marine Environmental Solutions AB (MESAB) | 2022-10-17 | $127m | n/d | n/d |
| IZI Medical | Halma | 2022-10-03 | $212m | n/d | 4.6x |
| Medi-Globe | DCC | 2022-09-12 | $276m | n/d | n/d |
| Standard Bariatrics | Teleflex | 2022-08-22 | $170m | n/d | n/d |
| B Medical Systems | Azenta | 2022-08-08 | $462m | n/d | n/d |
| Biorez | Conmed | 2022-08-01 | $85m | n/d | n/d |
| Guilin Zizhu | Winner Medical | 2022-06-06 | $67m | n/d | n/d |
| Pingan Medical | Winner Medical | 2022-06-01 | $102m | n/d | n/d |
| Impolin | Navamedic | 2022-05-05 | $6m | n/d | n/d |
| In2Bones | Conmed | 2022-05-04 | $145m | n/d | n/d |
| phenox | Wallaby Medical | 2022-04-21 | $563m | n/d | n/d |
| Aran Biomedical | Integer | 2022-04-07 | $135m | n/d | n/d |
| CartiHeal | Bioventus | 2022-04-04 | $315m | n/d | n/d |
| MD Orthopaedics | OrthoPediatrics | 2022-04-04 | $20m | n/d | n/d |
| Aspen Pharmacare Holdings - Prescription Medicines | Acino | 2022-03-01 | $118m | n/d | n/d |
| IntriCon | Altaris (PE) | 2022-02-28 | $241m | 40.6x | 1.9x |
| Cook Medical - Reproductive Health business | Cooper Companies | 2022-02-07 | $875m | n/d | 5.5x |
| Goodness Growth Holdings | Vireo Growth | 2022-02-04 | $413m | n/d | 7.8x |
| Letco Med | Fagron | 2022-02-02 | $34m | n/d | n/d |
| Biim Ultrasound | Observe Medical | 2022-01-14 | $22m | n/d | n/d |
| Alpaca Audiology | Sonova Holding | 2022-01-13 | $310m | n/d | n/d |
| HealthSmart International | Convey | 2022-01-10 | $78m | n/d | n/d |
| Kestrel Labs | Zynex | 2021-12-23 | $31m | n/d | n/d |
| Carestream Dental's Intra-Oral Scanner (IOS) Business | Envista | 2021-12-22 | $600m | n/d | n/d |
| OrthogenRx | Avanos | 2021-12-13 | $160m | n/d | n/d |
| Cardiovalve | Venus MedTech | 2021-12-07 | $300m | n/d | n/d |
| CIRS | Mirion | 2021-11-11 | $54m | n/d | n/d |
| Eton Bio | Codex DNA | 2021-11-09 | $13m | n/d | 2.6x |
| Ivantis | Alcon | 2021-11-08 | $475m | n/d | n/d |
| Volumetric | 3D Systems, 333 Three D Systems Circle | 2021-10-27 | $45m | n/d | n/d |
| CQ Medical | Blue Wolf Capital Partners (PE) | 2021-10-22 | $120m | n/d | n/d |
| Bolder Surgical | Hologic | 2021-10-14 | $160m | n/d | n/d |
| Hemovent | Shanghai MicroPort Medical | 2021-10-04 | $139m | n/d | n/d |
| QInstruments | BICO | 2021-10-01 | $69m | n/d | n/d |
| DERMAdoctor | NovaBay Pharma | 2021-09-28 | $15m | n/d | n/d |
| GraMedica | ADDvise Group AB (Publ) | 2021-09-15 | $6m | 6.8x | 1.7x |
| Itamar Medical | ZOLL Medical Corporation | 2021-09-13 | $538m | n/d | 11.2x |
| KaVo Dental | Planmeca Verwaltungs | 2021-09-07 | $455m | n/d | n/d |
| PA Natural Medicine | Ayr | 2021-09-01 | $80m | n/d | n/d |
| Ra Medical - Pharos Dermatology Business | STRATA | 2021-08-16 | $4m | n/d | n/d |
| Cenorin LLC - AquaGuard Business | TIDI | 2021-07-29 | $29m | n/d | n/d |
| Misonix | Bioventus | 2021-07-29 | $518m | n/d | 7.6x |
| Mathys | Enovis | 2021-07-28 | $285m | n/d | n/d |
| Paramit | Tecan Group Ltd. | 2021-06-23 | $956m | 20.0x | 3.6x |
| Alydia Health | Organon | 2021-06-16 | $240m | n/d | n/d |
| Propel Orthodontics | Dentsply Sirona | 2021-06-04 | $131m | n/d | n/d |
| Consensus Orthopedics | Shalby | 2021-05-17 | $11m | n/d | n/d |
| Immunodiagnostic Systems | Revvity | 2021-05-17 | $155m | n/d | 4.5x |
| Nexcelom Bioscience | Revvity | 2021-05-12 | $260m | n/d | n/d |
| Soliton | Allergan Aesthetics | 2021-05-10 | $550m | n/d | n/d |
The 150 most recent of 434 recorded transactions in this sector. n/d means not disclosed. Most transactions close without a published multiple, which is why the disclosed count matters more than the median. c: computed from the deal value in the 8-K and the target's own revenue in its SEC filings. w/h: the recorded multiple is implausible (outside 0.1x to 50x revenue or 1x to 80x EBITDA), so it is left out of every median. REIT: the target was a real estate investment trust, priced on its property portfolio rather than as an operating business, so its multiple is shown but left out of every median. stake: the price paid for part of the company, not the whole business, so it is left out of every deal-size median.
See all 434 Medical Products transactions
Medical Products acquisitions: questions the data answers
- Who buys Medical Products companies?
- In 434 recorded Medical Products transactions from 2014 to 2026, the most active acquirers were Boston Scientific (13), Merit Medical (9) and Medtronic (9). 65 of the 298 named buyers bought more than once, accounting for 196 of the deals.
- What EBITDA multiple do Medical Products companies sell for?
- The median disclosed EV/EBITDA is 10.5x, from 17 of 434 recorded transactions that published one (lowest 4.6x, highest 40.6x). The median EV/Revenue is 2.6x, from 88 deals. Most deals close without a published multiple, so these describe the larger, disclosed deals rather than every sale.
- How big are Medical Products acquisitions?
- The median disclosed deal value is $100m, from 414 of 434 transactions. 36% of those were under $50m and 1% were $1bn or more.
- Do private equity firms buy Medical Products companies?
- Yes. 26 of the 383 Medical Products deals recorded from 2014 to 2024 (7%) had a buyer the source labels private equity, most often Accelmed (2), Apax (2) and Altaris (1).
- Where are the buyers of Medical Products companies based?
- Of 385 deals where the buyer's head office is recorded, 65% were by buyers in the United States, 9% in the United Kingdom and 5% in Canada.
Who owns Healthcare & Life Sciences companies
On PEStore, Medical Products sits within Healthcare & Life Sciences. PEStore profiles the private equity firms and serial acquirers active there: what they own, how long they have held it, and every deal on record. Underlined acquirers above link to their profiles.
Healthcare & Life Sciences investors and acquirers on PEStoreMultiples across every sector
What is your Medical Products business worth?
Start with the free estimate against the current multiple band. It takes about a minute and shows the range and the method behind it. Every next step, and its price, is below.
Free
Valuation estimate
Your range from the multiple band for your sector, worked from your revenue or EBITDA. About a minute, emailed to you, no account.
Value my business$199
Written valuation report
Your range in a document you can hand to a partner, a lender or an accountant: the sector band with its date, comparable disclosed transactions, a sensitivity table and what would move your multiple.
Start with the calculator$495
An hour with a senior adviser
Sixty minutes on what the business is worth, who would buy it and what to fix first, with a written summary afterwards.
Book a sessionFree first call
Sell with our team
For profitable businesses with $1M or more of revenue planning a sale within two years. Our advisory team runs the process with you, from the first buyer list to close.
Talk to an adviser